SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410939-21-000045
Filing Date
2021-10-21
Accepted
2021-10-21 16:04:37
Documents
13
Period of Report
2021-10-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K isee-20211021.htm   iXBRL 8-K 41760
2 EX-99.1 october20218-kriskfactors.htm EX-99.1 519144
  Complete submission text file 0001410939-21-000045.txt   834038

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isee-20211021.xsd EX-101.SCH 1921
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isee-20211021_lab.xml EX-101.LAB 25154
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isee-20211021_pre.xml EX-101.PRE 13063
6 EXTRACTED XBRL INSTANCE DOCUMENT isee-20211021_htm.xml XML 10992
Mailing Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001
Business Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 211337052
SIC: 2834 Pharmaceutical Preparations